Diphtheria

  • Alakes Kumar Kole
  • Dalia Chanda Kole
Chapter

Abstract

Diphtheria, a highly contagious disease, is now rare in most countries but still endemic in many developing nations. Clinical features on presentation include sore throat, difficulty swallowing, low-grade fever, and an adherent pseudomembrane in the throat. Cardiac and neurologic complications may result from the potent exotoxin produced by Corynebacterium diphtheriae. Early diagnosis and prompt treatment with antitoxin, along with antibiotics, are essential for decreasing the risk of death. The only way to reduce the prevalence of diphtheria in endemic countries and prevent future epidemics is through complete vaccination of all children and booster vaccination of adults. This chapter reviews the epidemiology, clinical features, diagnosis, treatment, and prevention of diphtheria.

Keywords

Diphtheria Pseudomembrane Myocarditis Neurologic complications Polyneuropathy Outcomes 

Notes

Acknowledgement

The authors would like to thank Dr. Sumit Chakrabarty for his critical review of the manuscript and Mr. Asish Sikder for his technical support.

References

  1. 1.
    World Health Organization (WHO). WHO recommendations for routine immunization – summary tables. http://www.who.int/immunization/policy/immunization_tables/en/. Accessed May 2017.
  2. 2.
    Centers for Disease Control and Prevention (CDC). Recommended vaccination schedule for children and adolescents age 18 years or younger, United States, 2017. http://www.cdc.gov/vaccines/schedules/hcp/imz/child-adolescent.html. Accessed May 2017.
  3. 3.
    Centers for Disease Control and Prevention. The pink book: epidemiology and prevention of vaccine-preventable diseases. http://www.cdc.gov/vaccines/pubs/pinkbook/dip.html. Accessed May 2017.
  4. 4.
    Kadirova R, Kartoglu HU, Strebel PM. Clinical characteristics and management of 676 hospitalized diphtheria cases, Kyrgyz Republic, 1995. J Infect Dis. 2000;181(Suppl 1):S110–4.CrossRefGoogle Scholar
  5. 5.
    Centers for Disease Control and Prevention. Manual for surveillance for vaccine-preventable diseases; Chapter 1: Diphtheria. http://www.cdc.gov/vaccines/pubs/surv-manual/chpt01-dip.html, accessed May 2017.
  6. 6.
    Naiditch MJ, Bower AG. Diphtheria: a study of 1,433 cases observed during a ten-year period at the Los Angeles County Hospital. Am J Med. 1954;17:229–45.CrossRefGoogle Scholar
  7. 7.
    Pantukosit P, Arpornsuwan M, Sookananta K. A diphtheria outbreak in Buri Ram, Thailand. Southeast Asian J Trop Med Pub Health. 2008;39:690–6.Google Scholar
  8. 8.
    Kole AK, Roy R, Kar SS, Chanda D. Outcomes of respiratory diphtheria in a tertiary referral infectious disease hospital. Indian J Med Sci. 2010;64:373–7.CrossRefGoogle Scholar
  9. 9.
    Jain A, Samdani S, Meena V, Sharma MP. Diphtheria: It is still prevalent. Int J Pediatr Otorhinolaryngol. 2016;86:68–71.  https://doi.org/10.1016/j.ijporl.2016.04.024.CrossRefPubMedGoogle Scholar
  10. 10.
    Vitek CR, Wharton M. Diphtheria in the former Soviet Union: reemergence of a pandemic disease. Emerg Infect Dis. 1998;4:539–50.CrossRefGoogle Scholar
  11. 11.
    Centers for Disease Control and Prevention. Diphtheria epidemic – new independent states of the former Soviet Union 1990–1994. MMWR. 1995;44:177–81.Google Scholar
  12. 12.
    Santos LS, Sant'anna LO, Ramos JN, et al. Diphtheria outbreak in Maranhão, Brazil: microbiological, clinical and epidemiological aspects. Epidemiol Infect. 2015;143:791–8.CrossRefGoogle Scholar
  13. 13.
    Centers for Disease Control and Prevention. FDA approval of expanded age indication for a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. MMWR Morb Mortal Wkly Rep. 2009;58(14):374–5.Google Scholar
  14. 14.
    Maple PA, Efstratious A, George RC, et al. Diphtheria immunity in UK blood donors. Lancet. 1995;345:963–5.CrossRefGoogle Scholar
  15. 15.
    McQuillan GM, Kruszon-Moran D, Deforest A, et al. Serologic immunity to diphtheria and tetanus in the United States. Ann Intern Med. 2002;136:660–6.CrossRefGoogle Scholar
  16. 16.
    Damasco PV, Pimenta FP, Filardy AA, et al. Prevalence of IgG diphtheria antitoxin in blood donors in Rio de Janeiro. Epidemiol Infect. 2005;133:911–4.CrossRefGoogle Scholar
  17. 17.
    Mattos-Guaraldi AL, Moreira LO, Damasco PV, Hirata Júnior R. Diphtheria remains a threat to health in the developing world—an overview. Mem Inst Oswaldo Cruz. 2003;98:987–93.CrossRefGoogle Scholar
  18. 18.
    Wagner KS, White JM, Lucenko I, Mercer D, Crowcroft NS, Neal S. Diphtheria in post epidemic period, Europe, 2000–2009. Emerg Infect Dis. 2012;18:217–25.CrossRefGoogle Scholar
  19. 19.
    Chen RT, Broome CV, Weinstein RA, Weaver R, Tsai TF. Diphtheria in the United States, 1971–81. Am J Public Health. 1985;75:1393–7.CrossRefGoogle Scholar
  20. 20.
    Centers for Disease Control and Prevention. Diphtheria. http://www.cdc.gov/diphtheria/clinicians.html. Accessed May 2017.
  21. 21.
    World Health Organization. WHO vaccine-preventable diseases monitoring system, 2016 global summary. http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tsincidencediphtheria.html. Accessed May 2017.
  22. 22.
    Massachusetts Department of Public Health, Bureau of Communicable Disease Control. http://www.mass.gov/eohhs/docs/dph/disease-reporting/guide/diphtheria.pdf. Accessed May 2017.
  23. 23.
    Murhekar MV, Bitragunta S. Persistence of diphtheria in India. Indian J Community Med. 2011;36:164–5.CrossRefGoogle Scholar
  24. 24.
    Evdokimov K, Sayasinh K, Nouanthong P, et al. Low and disparate seroprotection after pentavalent childhood vaccination in the Lao People’s Democratic Republic: a cross-sectional study. Clin Microbiol Infect. 2017;23:197–202.CrossRefGoogle Scholar
  25. 25.
    Zasada AA, Baczewska-Rej M, Wardak S. An increase in non-toxigenic Corynebacterium diphtheriae infections in Poland – molecular epidemiology and antimicrobial susceptibility of strains isolated from past outbreaks and those currently circulating in Poland. Int J Infect Disease. 2010;14:907–12.CrossRefGoogle Scholar
  26. 26.
    Frobisher M Jr. The etiology of malignant diphtheria. Am J Public Health Nations Health. 1943;33:1244–56.CrossRefGoogle Scholar
  27. 27.
    Macgregor RR. Corynebacterium diphtheria. In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 8th ed. Philadelphia: Elsevier; 2015. p. 2366–72.Google Scholar
  28. 28.
    Singh J, Harit AK, Jain DC, Panda RC, Tewari KN, Bhatia R, et al. Diphtheria is declining, but continues to kill many children: analysis of data from a sentinel center in Delhi, 1997. Epidemiol Infect. 1999;123:209–15.CrossRefGoogle Scholar
  29. 29.
    Kole AK, Roy R, Kar SS. Cardiac involvement in diphtheria: study from a tertiary referral infectious disease hospital. Ann Trop Med Pub Health. 2012;5:202–6.Google Scholar
  30. 30.
    Lumio JT, Groundstroem KW, Melnick OB, Huhtala H, Rakhmanova AG. Electrocardiographic abnormalities in patients with diphtheria: a prospective study. Am J Med. 2004;116:78–83.CrossRefGoogle Scholar
  31. 31.
    Jayashree M, Shruthi N, Singhi S. Predictors of outcome in patients with diphtheria receiving intensive care. Indian Pediatr. 2006;43:155–60.PubMedGoogle Scholar
  32. 32.
    Hadfield TL, McEvoy P, Polotsky Y, Tzinserling VA, Yakovlev AA. The pathology of diphtheria. J Infect Dis. 2000;181(Suppl 1):S116–20.CrossRefGoogle Scholar
  33. 33.
    Stockins BA, Lanas FT, Saavedra JG, Opazo JA. Prognosis in patients with diphtheric myocarditis and bradyarrhythmias: assessment of results of ventricular pacing. Br Heart J. 1994;72:190–1.CrossRefGoogle Scholar
  34. 34.
    Kneen R, Dung NM, Solomon T, et al. Clinical features and predictors of diphtheritic cardiomyopathy in Vietnamese children. Clin Infect Dis. 2004;39:1591–8.CrossRefGoogle Scholar
  35. 35.
    Manikyamba D, Satvavani A, Deepa P. Diphtheritic polyneuropathy in the wake of resurgence of diphtheria. J Pediatr Neurosci. 2015;10:331–4.CrossRefGoogle Scholar
  36. 36.
    Sanghi V. Neurologic manifestations of diphtheria and pertussis. Handb Clin Neurol. 2014;121:1355–9.CrossRefGoogle Scholar
  37. 37.
    Logina I, Donaghy M. Diphtheritic polyneuropathy: a clinical study and comparison with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 1999;67:433–8.CrossRefGoogle Scholar
  38. 38.
    Mateen FJ, Bahl S, Khera A, SutterRW FJ. Detection of diphtheritic polyneuropathy by acute flaccid paralysis surveillance. India Emerg Infect. 2013;19:1370–3.CrossRefGoogle Scholar
  39. 39.
    Lumio J, Olander RM, Groundstroem K, Suomalainen P, Honkanen T, Vuopio-Varkila J. Epidemiology of three cases of severe diphtheria in Finnish patients with low antitoxin antibody levels. Eur J Clin Microbiol Infect Dis. 2001;20(10):705.CrossRefGoogle Scholar
  40. 40.
    de Benoist AC, White JM, Efstratiou A, Kelly C, Mann G, Nazareth B, et al. Imported cutaneous diphtheria, United Kingdom. Emerg Infect Dis. 2004;10(3):511–3.CrossRefGoogle Scholar
  41. 41.
    Hofler W. Cutaneous diphtheria. Int J Dermatol. 1991;30:845–7.CrossRefGoogle Scholar
  42. 42.
    Belsey MA, Sinclair M, Roder MR, LeBlanc DR. Corynebacterium diphtheriae skin infections in Alabama and Louisiana. A factor in the epidemiology of diphtheria. N Engl J Med. 1969;280(3):135–41.CrossRefGoogle Scholar
  43. 43.
    Pickering LK Red Book, diphtheria: report of the committee on infectious diseases, 25. Elk Grove Village, IL: American Academy of Pediatrics; 2000: 230–234.Google Scholar
  44. 44.
    Centers for Disease Control and Prevention. http://www.cdc.gov/diphtheria/downloads/dip-cklist-diag.pdf. Accessed May 2017.
  45. 45.
    Efstratiou A, Maple PAC. Manual for the laboratory diagnosis of diphtheria. Copenhagen: Expanded Programme on Immunization in the European Region of World Health Organization; 1994. ICP/EPI 038 (C).Google Scholar
  46. 46.
    Konrad R, Hörmansdorfer S, Sing A. Possible human-to-human transmission of toxigenic Corynebacterium ulcerans. Clin Microbiol Infect. 2015;21(8):768–71.CrossRefGoogle Scholar
  47. 47.
    Siegel JD, Rhinehart E, Jackson M, Chiarello L, Healthcare Inefection Control Practices Advisory Committee. Centers for Disease Control and Prevention. Guidelines for prevention of transmission of infection in healthcare settings. 2007. https://www.cdc.gov/infectioncontrol/pdf/guidelines/isolation-guidelines.pdf. Accessed May 2017.
  48. 48.
    Tiwari T, Clark T, Centers for Disease Control and Prevention. Use of diphtheria antitoxin (DAT) for suspected diphtheria cases, 3/14/2016. https://www.cdc.gov/diphtheria/downloads/protocol.pdf. Accessed May 2017.
  49. 49.
    Benamrouche N, Hasnaoui S, Badell E, et al. Microbiological and molecular characterization of Corynebacterium diphtheriae isolated in Algeria between 1992 and 2015. Clin Microbiol Infect. 2016;22:1005e1–7.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Alakes Kumar Kole
    • 1
  • Dalia Chanda Kole
    • 2
  1. 1.Department of MedicineNil Ratan Sircar Medical CollegeKolkataIndia
  2. 2.Peerless Hospital & B K Roy Research Centre, Chak Garia, Pancha SayarKolkataIndia

Personalised recommendations